Eli Lilly Settles Zyprexa Claims
Eli Lilly & Co. has reached settlements in about 18,000 claims that the company didn't properly disclose that patients taking Zyprexa, the company's schizophrenia drug, were at risk to develop diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article